Cat.#: ACPP-1366
| Despition | Dopamine D5 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1701 | Human SERPINA3 Protein (AC1701) | 5 µg | inquiry |
| ACPP-1760 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1760) | 100 µg | inquiry |
| ACPP-1212 | PAX8 Blocking Peptide (AC1212) | 250 µg | inquiry |
| ACPP-1784 | Human GPI Protein (AC1784) | 5 µg | inquiry |
| ACPP-1836 | Human CHGA Protein (AC1836) | 5 µg | inquiry |
| ACPP-1262 | CXCR4 Blocking Peptide (AC1262) | 250 µg | inquiry |
| ACPP-1072 | Synaptophysin Blocking Peptide (AC1072) | 250 µg | inquiry |
| ACPP-1409 | Human TULP1 Protein (AC1409) | 5 µg | inquiry |
| ACPP-1585 | Human SERPINI1 Protein, His (AC1585) | 2 µg | inquiry |
| ACPP-1791 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1791) | 100 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.